A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects - Concepedia

Concepedia

Publication | Open Access

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects

DOI Full Paper Access

477

Citations

36

References

2016

Year

Saswata Talukdar, Yingjiang Zhou, Dongmei Li, Michelle I. Rossulek, Jennifer Dong, Veena Somayaji, Yan Weng, Ronald W. Clark, Adhiraj Lanba, Bryn M. Owen,

Cell Metabolism

ObesityMetabolic SyndromeLong-acting Fgf21 MoleculeGrowth HormoneMetabolic DisorderMedicineDiabetesPhysiologyType 2Fibroblast Growth FactorBody WeightMetabolismPharmacologyCell BiologyHealth Sciences

References

	Year	Citations

Page 1

Page 1